Authors' Reply: Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD. Sridhar VS, Odutayo A, Davies MJ, Cherney DZI, et al. J Am Soc Nephrol 2025 Oct 10. doi: 10.1681/ASN.0000000868.

Read + Share

Amedeo Smart

Independent Medical Education

Sridhar VS, Odutayo A, Davies MJ, Cherney DZI, et al. Authors' Reply: Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD. J Am Soc Nephrol 2025 Oct 10. doi: 10.1681/ASN.0000000868.
PMID: 41071616